Patient info Open main menu

Xelevia 25 mg film-coated tablets – Summary of Product Characteristics (SmPC) for healthcare professionals

Medicine status: No longer supplied Details

Medicine strength:
25 mg
Contains active substance:
Similar medicines:

Summary of Product Characteristics (SmPC) - Xelevia 25 mg film-coated tablets

8 MARKETING AUTHORISATION NUMBER(S)

PLGB 53095/0080

9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

01/01/2021

Facts about Xelevia 25 mg film-coated tablets

Active substance Sitagliptin
Strength 25 mg
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. A Alimentary tract and metabolism drugs
    1. A10 Drugs used in diabetes
      1. A10B Blood glucose lowering drugs, excl. insulins
        1. A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors for blood glucose lowering
          1. A10BH01 sitagliptin

Sources: the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.